Anti-LAMA3/ BM600/ E170 functional antibody

Anti-LAMA3/ BM600/ E170 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to LAMA3/LAMA3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0297-Ab-1/ GM-Tg-hg-SE0297-Ab-2Anti-Human LAMA3 monoclonal antibodyHuman
GM-Tg-rg-SE0297-Ab-1/ GM-Tg-rg-SE0297-Ab-2Anti-Rat LAMA3 monoclonal antibodyRat
GM-Tg-mg-SE0297-Ab-1/ GM-Tg-mg-SE0297-Ab-2Anti-Mouse LAMA3 monoclonal antibodyMouse
GM-Tg-cynog-SE0297-Ab-1/ GM-Tg-cynog-SE0297-Ab-2Anti-Cynomolgus/ Rhesus macaque LAMA3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0297-Ab-1/ GM-Tg-felg-SE0297-Ab-2Anti-Feline LAMA3 monoclonal antibodyFeline
GM-Tg-cang-SE0297-Ab-1/ GM-Tg-cang-SE0297-Ab-2Anti-Canine LAMA3 monoclonal antibodyCanine
GM-Tg-bovg-SE0297-Ab-1/ GM-Tg-bovg-SE0297-Ab-2Anti-Bovine LAMA3 monoclonal antibodyBovine
GM-Tg-equg-SE0297-Ab-1/ GM-Tg-equg-SE0297-Ab-2Anti-Equine LAMA3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0297-Ab-1/ GM-Tg-hg-SE0297-Ab-2; GM-Tg-rg-SE0297-Ab-1/ GM-Tg-rg-SE0297-Ab-2;
GM-Tg-mg-SE0297-Ab-1/ GM-Tg-mg-SE0297-Ab-2; GM-Tg-cynog-SE0297-Ab-1/ GM-Tg-cynog-SE0297-Ab-2;
GM-Tg-felg-SE0297-Ab-1/ GM-Tg-felg-SE0297-Ab-2; GM-Tg-cang-SE0297-Ab-1/ GM-Tg-cang-SE0297-Ab-2;
GM-Tg-bovg-SE0297-Ab-1/ GM-Tg-bovg-SE0297-Ab-2; GM-Tg-equg-SE0297-Ab-1/ GM-Tg-equg-SE0297-Ab-2
Products NameAnti-LAMA3 monoclonal antibody
Formatmab
Target NameLAMA3
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-LAMA3 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0297-Ag-1Recombinant multi-species LAMA3/ BM600/ E170 protein


    Target information

    Target IDGM-SE0297
    Target NameLAMA3
    Gene ID3909,16774,307582,701313,480173,101100161,100336873,791238
    Gene Symbol and SynonymsBM600,E170,JEB2A,JEB2B,JEB2C,LAMA3,Lama3B,LAMNA,LOCS,[a]3B
    Uniprot AccessionQ16787
    Uniprot Entry NameLAMA3_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000053747
    Target ClassificationN/A

    The target: LAMA3, gene name: LAMA3, also named as BM600, E170, LAMNA, LOCS. The protein encoded by this gene belongs to the laminin family of secreted molecules. Laminins are heterotrimeric molecules that consist of alpha, beta, and gamma subunits that assemble through a coiled-coil domain. Laminins are essential for formation and function of the basement membrane and have additional functions in regulating cell migration and mechanical signal transduction. This gene encodes an alpha subunit and is responsive to several epithelial-mesenchymal regulators including keratinocyte growth factor, epidermal growth factor and insulin-like growth factor. Mutations in this gene have been identified as the cause of Herlitz type junctional epidermolysis bullosa and laryngoonychocutaneous syndrome. Alternative splicing and alternative promoter usage result in multiple transcript variants. [provided by RefSeq, Dec 2014].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.